Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy

被引:6
|
作者
Zhou, M [1 ]
Hayasaka, S
Taylor, JMG
Shah, R
Proverbs-Singh, T
Manley, S
Rubin, MA
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Urol Sect, Ann Arbor, MI USA
关键词
prostate; prostatic neoplasms; prostate-specific antigen; prostatectomy;
D O I
10.1016/S0022-5347(05)65533-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Grading prostate cancer using the Gleason system relies only on architectural tumor growth, in contrast to other systems, such as the WHO system, which grade prostate carcinoma based on nuclear features as well as architectural patterns. The prognostic significance of nuclear grading remains controversial since most studies were performed before prostate specific antigen (PSA) screening became widely available. We evaluated the significance of nuclear grade for predicting PSA recurrence in a contemporary cohort of patients treated with radical prostatectomy for clinically localized prostate carcinoma. Materials and Methods: Nuclear grades 1 to 3 were determined in 141 consecutive radical prostatectomies in 1995. Predominant and worst nuclear grade was determined by a consensus of 3 pathologists. Statistical analysis compared nuclear grade with Gleason score using the chi-square test. The Cox proportional hazards analysis was performed to calculate the ability of nuclear grade, Gleason score and other variables to predict PSA recurrence. Results: We identified a significant association of Gleason score with worst nuclear grade (p = 0.007). All 6 cases with a Gleason score of 8 or greater had a worst nuclear grade of 3, in contrast to 36 of 60 (60%) with a score 6 or less, in which the worst nuclear grade was 3. Of the 141 patients 31 (21.9%) had PSA recurrence at a median followup of 3.7 years. The univariate Cox model revealed significant associations of PSA recurrence with Gleason score 8 or greater (hazards ratio 5.5, p = 0.005), extraprostatic extension (hazards ratio 3.4, p = 0.001), positive surgical margin (hazards ratio 2.6, p = 0.009), seminal vesicle involvement (hazards ratio 7.3, p <0.001), preoperative serum PSA (hazards ratio 1.03, p = 0.007), tumor stage (hazards ratio 3.6, p = 0.001) and maximal tumor dimension (:hazards ratio 2.4, p <0.001). However, overall and worst nuclear grade did not predict PSA recurrence (p = 0.89 and 0.13, respectively). Nuclear grade did not fit any multivariate model tested, which otherwise included Gleason score, log(PSA), surgical margin status, extraprostatic extension, seminal vesicle status, tumor size and pathological stage. By varying sample fixation time we also showed that benign prostate tissue in the same section as prostate carcinoma had grade 2 or 3 nuclear changes, that is moderate to marked anaplasia. Conclusions: High nuclear grade is associated with high Gleason score. However, prostate carcinoma with a Gleason score of 6 or less shows extreme variability. Nuclear grade determined by light microscopy failed to predict PSA recurrence in a contemporary series of men with clinically localized prostate cancer treated with radical prostatectomy. Nuclear morphology is subject to tissue fixation and processing artifact. Any nuclear morphometric study must consider this artifact.
引用
收藏
页码:2193 / 2197
页数:5
相关论文
共 50 条
  • [1] Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality
    Freedland, Stephen J.
    Humphreys, Elizabeth B.
    Mangold, Leslie A.
    Eisenberger, Mario
    Partin, Alan W.
    JOURNAL OF UROLOGY, 2006, 176 (04) : 1404 - 1408
  • [2] Tumor Percent Involvement Predicts Prostate Specific Antigen Recurrence After Radical Prostatectomy Only in Men With Smaller Prostate
    Uhlman, Matthew A.
    Sun, Leon
    Stackhouse, Danielle A.
    Polascik, Thomas J.
    Mouraviev, Valdmir
    Robertson, Cary N.
    Albala, David M.
    Moul, Judd W.
    JOURNAL OF UROLOGY, 2010, 183 (03) : 997 - 1001
  • [3] Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy
    Magheli, Ahmed
    Rais-Bahrami, Soroush
    Trock, Bruce J.
    Humphreys, Elizabeth B.
    Partin, Alan W.
    Han, Misop
    Gonzalgo, Mark L.
    JOURNAL OF UROLOGY, 2008, 179 (05) : 1780 - 1784
  • [4] Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: Results from the search data base
    Freedland, SJ
    Kane, CJ
    Presti, JC
    Terris, MK
    Amling, CL
    Dorey, F
    Aronson, WJ
    JOURNAL OF UROLOGY, 2003, 169 (03) : 969 - 973
  • [5] Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille, A
    Rubin, MA
    Bagiella, E
    Olsson, CA
    Buttyan, R
    Burchardt, T
    Knight, C
    O'Toole, KM
    Katz, AE
    JOURNAL OF UROLOGY, 1999, 162 (01) : 103 - 106
  • [6] Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
    Patel, A
    Dorey, F
    Franklin, J
    deKernion, JB
    JOURNAL OF UROLOGY, 1997, 158 (04) : 1441 - 1445
  • [7] Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins
    Simon, MA
    Kim, S
    Soloway, MS
    JOURNAL OF UROLOGY, 2006, 175 (01) : 140 - 144
  • [8] Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy
    Moul, JW
    Wu, HY
    Sun, L
    McLeod, DG
    Amling, C
    Donahue, T
    Kusuda, L
    Sexton, W
    O'Reilly, K
    Hernandez, J
    Chung, A
    Soderdahl, D
    JOURNAL OF UROLOGY, 2004, 171 (03) : 1141 - 1147
  • [9] Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy
    Graefen, M
    Karakiewicz, PI
    Cagiannos, I
    Hammerer, PG
    Haese, A
    Palisaar, J
    Huland, E
    Scardino, PT
    Kattan, MW
    Huland, H
    JOURNAL OF UROLOGY, 2002, 167 (03) : 1306 - 1309
  • [10] Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy
    Soergel, TM
    Koch, MO
    Foster, RS
    Bihrle, R
    Wahle, G
    Gardner, T
    Jung, SH
    JOURNAL OF UROLOGY, 2001, 166 (06) : 2198 - 2201